Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages
Open accessAbstract
Antibody-dependent enhancement of virus infection is a process whereby virus-antibody complexes initiate infection of cells via Fc receptor-mediated endocytosis. We sought to investigate antibody-dependent enhancement of feline infectious peritonitis virus infection of primary feline peritoneal macrophages in vitro. Enhancement of infection was assessed, after indirect immunofluorescent-antibody labelling of infected cells, by determining the ratio between the number of cells infected in the presence and absence of virus-specific antibody. Infection enhancement was initially demonstrated by using heat-inactivated, virus-specific feline antiserum. Functional compatibility between murine immunoglobulin molecules and feline Fc receptors was demonstrated by using murine anti-sheep erythrocyte serum and an antibody-coated sheep erythrocyte phagocytosis assay. Thirty-seven murine monoclonal antibodies specific for the nucleocapsid, membrane, or spike proteins of feline infectious peritonitis virus or transmissible gastroenteritis virus were assayed for their ability to enhance the infectivity of feline infectious peritonitis virus. Infection enhancement was mediated by a subset of spike protein-specific monoclonal antibodies. A distinct correlation was seen between the ability of a monoclonal antibody to cause virus neutralization in a routine cell culture neutralization assay and its ability to mediate infection enhancement of macrophages. Infection enhancement was shown to be Fc receptor mediated by blockade of antibody-Fc receptor interaction using staphylococcal protein A. Our results are consistent with the hypothesis that antibody-dependent enhancement of feline infectious peritonitis virus infectivity is mediated by antibody directed against specific sites on the spike protein.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Compared with full-length S protein, RBD antigen may induce fewer non-neutralizing antibodies, lowering the risk of potential ADE of SARS-CoV-2 infection.
“Compared with the full-length S protein, RBD antigen may induce fewer non-neutralizing antibodies, lowering the risk of potential ADE of SARS-CoV-2 infection”
From A thermostable mRNA vaccine against COVID-19 (2020) · cites this paper as Olsen et al., 1992
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & Muench, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 20,341 · see citing works
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,377 · see citing works
Mackett, M., Smith, G. L., & Moss, B. (1984) · Journal of Virology · doi:10.1128/jvi.49.3.857-864.1984 · Cited by 643 · see citing works
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
Mackett, M., Smith, G. L., & Moss, B. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.23.7415 · Cited by 640 · see citing works
Antibody-Enhanced Infection by HIV-1 Via Fc Receptor-Mediated Entry
Takeda, A., Tuazon, C. U., & Ennis, F. A. (1988) · Science · doi:10.1126/science.2972065 · Cited by 461 · see citing works
The Fc and not CD4 Receptor Mediates Antibody Enhancement of HIV Infection in Human Cells
Homsy, J., Meyer, M., Tateno, M., et al. (1989) · Science · doi:10.1126/science.2786647 · Cited by 331 · see citing works
CORONAVIRUS: ORGANIZATION, REPLICATION AND EXPRESSION OF GENOME
Lai, M. M. C. (1990) · Annual Review of Microbiology · doi:10.1146/annurev.mi.44.100190.001511 · Cited by 301 · see citing works
Smith, G. L., Murphy, B. R., & Moss, B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.23.7155 · Cited by 295 · see citing works
Vennema, H., de Groot, R. J., Harbour, D. A., Dalderup, M. J. M., Gruffydd-Jones, T., Horzinek, M. C., & Spaan, W. J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1407-1409.1990 · Cited by 276 · see citing works
Weiss, R. C., & Scott, F. W. (1981) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/0147-9571(81)90003-5 · Cited by 242 · see citing works
Self-citationPanicali, D., Davis, S. W., Weinberg, R., & Paoletti, E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5364 · Cited by 228 · see citing works
Antibody-Dependent Enhancement of Viral Infectivity
Porterfield, J. S. (1986) · Advances in virus research · doi:10.1016/s0065-3527(08)60268-7 · Cited by 204 · see citing works
Henchal, E. A., Burke, D. S., Brandt, W. E., et al. (1985) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1985.34.162 · Cited by 199 · see citing works
Corapi, W. V., Donis, R. O., & Dubovi, E. J. (1990) · American Journal of Veterinary Research · doi:10.2460/ajvr.1990.51.09.1388 · Cited by 176 · see citing works
Self-citationHomsy, J., Meyer, M., & Levy, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1437-1440.1990 · Cited by 155 · see citing works
Immunologic Phenomena in the Effusive Form of Feline Infectious Peritonitis
Pedersen, N. C., & Boyle, J. F. (1980) · American Journal of Veterinary Research · doi:10.2460/ajvr.1980.41.06.868 · Cited by 154 · see citing works
A new mechanism for the neutralization of enveloped viruses by antiviral antibody
Gollins, S., & Porterfield, J. S. (1986) · Nature · doi:10.1038/321244a0 · Cited by 152 · see citing works
Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages
Peiris, M. J. S., Gordon, S., Unkeless, J. C., et al. (1981) · Nature · doi:10.1038/289189a0 · Cited by 142 · see citing works
Gollins, S., & Porterfield, J. S. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-8-1261 · Cited by 132 · see citing works
Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
Halstead, S. B., Venkateshan, C. N. S., Gentry, M. K., et al. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1529 · Cited by 128 · see citing works
Stoddart, C. A., & Scott, F. W. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.436-440.1989 · Cited by 128 · see citing works
Self-citationIntracellular transport of recombinant coronavirus spike proteins: implications for virus assembly
Vennema, H., Heijnen, L., Zijderveld, A., et al. (1990) · Journal of Virology · doi:10.1128/jvi.64.1.339-346.1990 · Cited by 123 · see citing works
Robinson, W. E., Kawamura, T., Górny, M. K., Lake, D. F., Xu, J. Y., Matsumoto, Y., Sugano, T., Masuho, Y., Mitchell, W. M., & Hersh, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3185 · Cited by 122 · see citing works
Morens, D. M., & Halstead, S. B. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-12-2909 · Cited by 121 · see citing works
Pathogenesis of feline infetious peritonitis: pathologic changes and immunofluorescence.
Weiss, R. C., & Scott, F. (1981) · PubMed · Cited by 117 · see citing works
Self-citationPathogenesis of Feline Infectious Peritonitis: Nature and Development of Viremia
Weiss, R. C., & Scott, F. (1981) · American Journal of Veterinary Research · doi:10.2460/ajvr.1981.42.03.382 · Cited by 101 · see citing works
Self-citationSchlesinger, J. J., & BRANDRISS, M. W. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.2.659 · Cited by 96 · see citing works
Jacobse-Geels, H. E. L., Daha, M. R., & Horzinek, M. C. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1606 · Cited by 77 · see citing works
Jacobse-Geels, H. E. L., Daha, M. R., & Horzinek, M. C. (1982) · American Journal of Veterinary Research · doi:10.2460/ajvr.1982.43.04.666 · Cited by 73 · see citing works
Krilov, L. R., Anderson, L. J., Marcoux, L., Bonagura, V. R., & Wedgwood, J. F. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.777 · Cited by 69 · see citing works
Fiscus, S. A., & Teramoto, Y. A. (1987) · Journal of Virology · doi:10.1128/jvi.61.8.2607-2613.1987 · Cited by 68 · see citing works
Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1
Ochiai, H., Kurokawa, M., Hayashi, K., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.20-26.1988 · Cited by 65 · see citing works
Morens, D. M., Venkateshan, C. N. S., & Halstead, S. B. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-1-91 · Cited by 57 · see citing works
In vitro Enhancement of Respiratory Syncytial Virus Infection of U937 Cells by Human Sera
Gimenez, H. B., Keir, H. M., & Cash, P. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-89 · Cited by 54 · see citing works
Antibody-mediated Enhancement of Rabies Virus Infection in a Mouse Macrophage Cell Line (P388D1)
King, A. A., Sands, J. J., & Porterfield, J. S. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-6-1091 · Cited by 46 · see citing works
Jolly, P. E., Huso, D. L., Sheffer, D., et al. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1811-1813.1989 · Cited by 32 · see citing works
Schlesinger, J. J., & BRANDRISS, M. W. (1981) · Journal of Medical Virology · doi:10.1002/jmv.1890080204 · Cited by 32 · see citing works
Morens, D. M., & Halstead, S. B. (1987) · Journal of Medical Virology · doi:10.1002/jmv.1890220208 · Cited by 30 · see citing works
Schlesinger, J. J., & BRANDRISS, M. W. (1983) · Journal of General Virology · doi:10.1099/0022-1317-64-6-1255 · Cited by 29 · see citing works
Ochiai, H., Kurokawa, M., Kuroki, Y., et al. (1990) · Journal of Medical Virology · doi:10.1002/jmv.1890300406 · Cited by 28 · see citing works
Stoddart, C. A., & Scott, F. W. (1988) · Journal of Leukocyte Biology · doi:10.1002/jlb.44.5.319 · Cited by 26 · see citing works
Self-citationAntibody-Mediated Enhancement of Dengue Virus Infection in Mouse Macrophage Cell Lines, Mk1 and Mm1
Hotta, H., Wiharta, A. S., & Hotta, S. (1984) · Experimental Biology and Medicine · doi:10.3181/00379727-175-41802 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rapid COVID-19 vaccine development
Graham, B. S. (2020) · Science · doi:10.1126/science.abb8923 · Cited by 771 · see citing works
A thermostable mRNA vaccine against COVID-19
Zhang, N.-N., Li, X.-F., Deng, Y.-Q., Zhao, H., Huang, Y.-J., Yang, G., Huang, W.-J., Gao, P., Zhou, C., Zhang, R.-R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.024 · Cited by 671 · see citing works
“Compared with the full-length S protein, RBD antigen may induce fewer non-neutralizing antibodies, lowering the risk of potential ADE of SARS-CoV-2 infection; a similar phenomenon has been observed during other coronavirus infection experiments (Olsen et al., 1992).”
Rauch, S., Roth, N., Schwendt, K., Fotin-Mleczek, M., Mueller, S. O., & Petsch, B. (2021) · npj Vaccines · doi:10.1038/s41541-021-00311-w · Cited by 165 · see citing works
Zang, J., Gu, C., Zhou, B., Zhang, C., Yang, Y., Xu, S., Bai, L., Zhang, R., Deng, Q., Yuan, Z., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00199-1 · Cited by 67 · see citing works
- Authors
- Olsen, C. W., Corapi, W. V., Ngichabe, C. K., Baines, J. D., & Scott, F. W.
- Affiliations
- Cornell University (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1992-02
- Volume
- 66
- Issue
- 2
- Pages
- 956-965
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC240797
- OpenAlex
- W2159989855
- Cited by
- 179
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 10 · 2020: 25 · 2019: 5 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 5 · 2013: 2 · 2012: 2
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- feline infectious peritonitis virus, antibody-dependent enhancement, spike protein, monoclonal antibodies, Fc receptors, virus neutralization, transmissible gastroenteritis virus, endocytosis
- MeSH terms
- Animals, Antibodies, Monoclonal, Ascites, Cats, Cell Line, Cells, Cultured, Immunoglobulin Fc Fragments, Macrophages, Phagocytosis, Staphylococcal Protein A, Viral Envelope Proteins, Virulence, Coronavirus, Feline, Feline Infectious Peritonitis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review